At 0.5 μg, TNFα‐CSG led to a significant increase in intratumoral CD8+ T cells and macrophages (CD11b+ F480+ Ly6G−) but reduced the population of tumour myeloid‐derived suppressor cells (CD11b+ F480− Ly6G+) (Fig EV3C). The gene discussed is CD8A; the disease is neoplasm.